Tag Archives: Authorizes

Coronavirus (COVID-19) Replace: FDA Authorizes First Oral Antiviral for Therapy of COVID-19

[ad_1] For Quick Launch: December 22, 2021 Español As we speak, the U.S. Meals and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the therapy of mild-to-moderate coronavirus illness (COVID-19) in adults and pediatric sufferers (12 years of age and older weighing… Read More »

FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Kids 5 via 11 Years of Age

[ad_1] For Quick Launch: October 29, 2021 Español In the present day, the U.S. Meals and Drug Administration approved the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to incorporate youngsters 5 via 11 years of age. The authorization was primarily based on the FDA’s thorough and clear analysis of the… Read More »